Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merck & Co Inc (NYSE:MRK)

62.33
Delayed Data
As of Apr 28
 -0.25 / -0.40%
Today’s Change
53.06
Today|||52-Week Range
66.80
+5.88%
Year-to-Date
2 'Swing for the Fences' Small Biotechs
Apr 28 / TheStreet.com - Paid Partner Content
Bristol-Myers (BMY) Beats on Q1 Earnings, Ups 2017 View
Apr 27 / Zacks.com - Paid Partner Content
Seattle Genetics (SGEN) Q1 Loss Widens, Sales Top Estimates
Apr 28 / Zacks.com - Paid Partner Content
Breton Hill Capital Ltd. Buys Philip Morris International, Pfizer, Reynolds American,...
Apr 26 / GuruFocus News - Paid Partner Content
Pharma Stock Roundup: Lilly, Bristol-Myers, Novartis Q1 Earnings & More
Apr 28 / Zacks.com - Paid Partner Content
Surveying the NASH Drug Landscape
Apr 26 / TheStreet.com - Paid Partner Content
What Happened The Last Time Companies Got A Tax-Break On Overseas Cash?
Apr 27 / Investing Channel - Paid Partner Content
What's in Store for Merck (MRK) this Earnings Season?
Apr 26 / Zacks.com - Paid Partner Content
Agran Libbie Buys 3M Co, Douglas Emmett, Alerian MLP, Sells Martin Midstream Partners...
Apr 27 / GuruFocus News - Paid Partner Content
Surveying the NASH Liver-Disease Drug Landscape
Apr 26 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close62.58
Today’s open62.58
Day’s range62.14 - 62.65
Volume9,461,664
Average volume (3 months)10,025,794
Market cap$171.6B
Dividend yield3.02%
Data as of 4:00pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)-9.62%
Earnings growth (this year)+0.54%
Earnings growth (next 5 years)+4.70%
Revenue growth (last year)+1.86%
P/E ratio44.2
Price/Sales4.15
Price/Book4.29

Competitors

 Today’s
change
Today’s
% change
NVSNovartis-0.03-0.04%
PFEPfizer+0.06+0.18%
SNYSanofi+0.39+0.83%
ABBVAbbVie-0.13-0.20%
Data as of 4:02pm ET, 04/28/2017

Financials

Next reporting dateMay 2, 2017
EPS forecast (this quarter)$0.83
Annual revenue (last year)$39.5B
Annual profit (last year)$3.9B
Net profit margin9.93%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
Kenneth C. Frazier
Chief Financial Officer &
Executive Vice President
Robert M. Davis
Corporate headquarters
Kenilworth, New Jersey

Forecasts